...
首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
【24h】

Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)

机译:草药(植物治疗剂)的功效,安全性,质量控制,市场营销和法规指南

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This review highlights the current advances in knowledge about the safety, efficacy, quality control, marketing and regulatory aspects of botanical medicines. Phytotherapeutic agents are standardized herbal preparations consisting of complex mixtures of one or more plants which contain as active ingredients plant parts or plant material in the crude or processed state. A marked growth in the worldwide phytotherapeutic market has occurred over the last 15 years. For the European and USA markets alone, this will reach about $7 billion and $5 billion per annum, respectively, in 1999, and has thus attracted the interest of most large pharmaceutical companies. Insufficient data exist for most plants to guarantee their quality, efficacy and safety. The idea that herbal drugs are safe and free from side effects is false. Plants contain hundreds of constituents and some of them are very toxic, such as the most cytotoxic anti-cancer plant-derived drugs, digitalis and the pyrrolizidine alkaloids, etc. However, the adverse effects of phytotherapeutic agents are less frequent compared with synthetic drugs, but well-controlled clinical trials have now confirmed that such effects really exist. Several regulatory models for herbal medicines are currently available including prescription drugs, over-the-counter substances, traditional medicines and dietary supplements. Harmonization and improvement in the processes of regulation is needed, and the general tendency is to perpetuate the German Commission E experience, which combines scientific studies and traditional knowledge (monographs). Finally, the trend in the domestication, production and biotechnological studies and genetic improvement of medicinal plants, instead of the use of plants harvested in the wild, will offer great advantages, since it will be possible to obtain uniform and high quality raw materials which are fundamental to the efficacy and safety of herbal drugs.
机译:这篇综述重点介绍了有关植物药的安全性,功效,质量控制,市场营销和法规方面的最新知识。植物治疗剂是标准化的草药制剂,由一种或多种植物的复杂混合物组成,这些植物的原始或加工状态含有植物部分或植物材料作为活性成分。在过去的15年中,全球植物治疗药物市场出现了显着增长。仅就欧洲和美国市场而言,1999年将分别达到约70亿美元和50亿美元,因此吸引了大多数大型制药公司的兴趣。大多数植物的数据不足,无法保证其质量,功效和安全性。草药药物安全且无副作用的想法是错误的。植物包含数百种成分,其中一些具有很高的毒性,例如最具细胞毒性的抗癌植物衍生药物,洋地黄和吡咯烷嗪生物碱等。但是,与合成药物相比,植物治疗剂的不良反应较少,但是经过良好控制的临床试验现已证实这种作用确实存在。当前有几种草药监管模式,包括处方药,非处方药,传统药物和膳食补充剂。监管过程需要协调和改善,总的趋势是使德国委员会E的经验永存,这种经验将科学研究和传统知识(专着)结合在一起。最后,药用植物的驯化,生产和生物技术研究以及遗传改良的趋势将提供巨大的优势,而不是使用在野外收获的植物,因为这将有可能获得均一且高质量的原料。草药功效和安全的根本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号